Aequus Announces Issuance of Stock Options
December 08, 2020 21:13 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Provides Third Quarter 2020 Financial Highlights
November 30, 2020 09:00 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Announces Anne Stevens’ Leadership Change
November 12, 2020 20:30 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), a specialty pharmaceutical company with a focus on developing, advancing and...
Aequus Receives Approval for New ‘Evolve - Daily Intensive’ Lubricating Eye Drops in Canada
October 29, 2020 08:00 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company announced today...
Aequus Receives Approval for New ‘Evolve - Intensive Gel’ Lubricating Eye Drops in Canada
October 19, 2020 08:00 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company announced today...
Aequus Extends Commercial Agreement for Specialty Product Tacrolimus IR in Canada
October 16, 2020 08:00 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), announced today that it has agreed to an extension...
Aequus Announces Expansion of Medicom Partnership and Filing with Health Canada for Additional Evolve Dry Eye Product
September 22, 2020 09:37 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company announced today...
Aequus Announces Filing of New Medical Device License for Evolve Dry Eye Products in Canada
September 14, 2020 12:50 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company announced today...
Aequus Prepares for Health Canada Regulatory Filing as Partner Receives MDSAP Certificate for Dry Eye Products
August 31, 2020 08:30 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Provides General Update and Second Quarter 2020 Financial Highlights
August 27, 2020 21:30 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...